<DOC>
	<DOCNO>NCT00858325</DOCNO>
	<brief_summary>The primary objective study characterise pharmacokinetics dose proportionality daptomycin single multiple ( daily ) 4mg/kg 6 mg/kg dos daptomycin healthy Chinese volunteer .</brief_summary>
	<brief_title>Pharmacokinetic Study Daptomycin Healthy Chinese Subjects Living China</brief_title>
	<detailed_description />
	<mesh_term>Daptomycin</mesh_term>
	<criteria>Men woman ( childbearing potential ) Chinese ethnicity Weight 55Kg 90Kg Body Mass Index ( BMI ) 18 25 kg/m2 Have calculate creatinine clearance within range 80 120 ml/min inclusive Unable discontinue use HMGCoA reductase inhibitor therapy within 7 day prior first dose study drug discharge unit CPK &gt; 2X ULN ( upper limit normal )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Cubicin</keyword>
	<keyword>PK</keyword>
	<keyword>China Registration</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>